Carl Dambkowski - Net Worth and Insider Trading

Carl Dambkowski Net Worth

The estimated net worth of Carl Dambkowski is at least $10 Million dollars as of 2025-05-05. Carl Dambkowski is the Chief Medical Officer of Apogee Therapeutics Inc and owns about 247,173 shares of Apogee Therapeutics Inc (APGE) stock worth over $10 Million. Details can be seen in Carl Dambkowski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Dambkowski has not made any transactions after 2025-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Carl Dambkowski

To

Carl Dambkowski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carl Dambkowski owns 1 companies in total, including Apogee Therapeutics Inc (APGE) .

Click here to see the complete history of Carl Dambkowski’s form 4 insider trades.

Insider Ownership Summary of Carl Dambkowski

Ticker Company Transaction Date Type of Owner
APGE Apogee Therapeutics Inc 2025-04-02 Chief Medical Officer

Carl Dambkowski Latest Holdings Summary

Carl Dambkowski currently owns a total of 1 stock. Carl Dambkowski owns 247,173 shares of Apogee Therapeutics Inc (APGE) as of April 2, 2025, with a value of $10 Million.

Latest Holdings of Carl Dambkowski

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APGE Apogee Therapeutics Inc 2025-04-02 247,173 40.12 9,916,581

Holding Weightings of Carl Dambkowski


Carl Dambkowski Form 4 Trading Tracker

According to the SEC Form 4 filings, Carl Dambkowski has made a total of 10 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Apogee Therapeutics Inc is the sale of 3,860 shares on April 2, 2025, which brought Carl Dambkowski around $139,809.

Insider Trading History of Carl Dambkowski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carl Dambkowski Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carl Dambkowski Ownership Network

Ownership Network List of Carl Dambkowski

No Data

Ownership Network Relation of Carl Dambkowski

Insider Network Chart

Carl Dambkowski's Executive Compensation Overview

Company Year Salary($) Bonus($) Stock Awards($) Option Awards($) Equity Awards($) Non-Equity Incentive Plan($) All Other Compensation($) Change in Pension and Deferred Comp($) Total($)
Apogee Therapeutics Inc 2023 477,083 393,750 N/A 3,300,000 N/A N/A 0 N/A 4,170,833
LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT

Carl Dambkowski Owned Company Details

What does Apogee Therapeutics Inc do?

Who are the key executives at Apogee Therapeutics Inc?

Carl Dambkowski is the Chief Medical Officer of Apogee Therapeutics Inc. Other key executives at Apogee Therapeutics Inc include director & Chief Executive Officer Michael Thomas Henderson , and Chief Financial Officer Jane Henderson .

Apogee Therapeutics Inc (APGE) Insider Trades Summary

Over the past 18 months, Carl Dambkowski made 10 insider transaction in Apogee Therapeutics Inc (APGE) with a net sale of 55,995. Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net sale of 195,000 shares made by Michael Thomas Henderson , a net purchase of 20,000 shares made by Mark C. Mckenna , and a net sale of 6,000 shares made by Jane Henderson .

In summary, during the past 3 months, insiders sold 3,860 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 3,860 shares. During the past 18 months, 256,995 shares of Apogee Therapeutics Inc (APGE) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 236,995 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apogee Therapeutics Inc Insider Transactions

No Available Data

Carl Dambkowski Mailing Address

Above is the net worth, insider trading, and ownership report for Carl Dambkowski. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Carl Dambkowski's mailing address is: Waltham Ma 02453.